Success Metrics

Completion Rate

0%(0/1)

Active Trials

2(29%)

Terminated

1(14%)

Phase Distribution

Ph phase_1

29%

Ph phase_3

29%

Ph phase_2

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

2(40.0%)

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Terminated(2)

Other(2)

Detailed Status

unknown2

Recruiting1

Withdrawn1

Terminated1

Active, not recruiting1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (40.0%)

Phase 21 (20.0%)

Phase 32 (40.0%)

Trials by Status

recruiting114%

withdrawn114%

terminated114%

active_not_recruiting114%

not_yet_recruiting114%

unknown229%

Recent Activity

2 active trials

Showing 5 of 7

terminatedphase_3

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

NCT05223647

withdrawnphase_2

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

NCT06866951

active_not_recruitingphase_3

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

NCT03836261

not_yet_recruiting

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

NCT06591910

recruitingphase_1

Radiotherapy to All Residual Lesions After Chemoimmunotherapy

NCT06479473

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT05223647Phase 3

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

Terminated

NCT06866951Phase 2

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

Withdrawn

NCT03836261Phase 3

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

Active Not Recruiting

NCT06591910

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Not Yet Recruiting

NCT06479473Phase 1

Radiotherapy to All Residual Lesions After Chemoimmunotherapy

Recruiting

NCT04465942

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Unknown

NCT04873440Phase 1

An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma